US 11,925,661 B2
Ready-to-use potassium phosphates in sodium chloride solutions
Brijeshkumar B. Pandya, Sacramento, CA (US); Govind R. Jagadale, Sacramento, CA (US); Dasaradhi Lakkaraju, Sacramento, CA (US); Bala Tripura Sundari Chodavarapu, Davis, CA (US); Anand Shukla, Denver, CO (US); and Jwalant Shukla, Sacramento, CA (US)
Assigned to Nivagen Pharmaceuticals, Inc., Sacramento, CA (US)
Filed by Nivagen Pharmaceuticals, Inc., Sacramento, CA (US)
Filed on Sep. 5, 2023, as Appl. No. 18/460,941.
Application 18/460,941 is a continuation in part of application No. 17/499,001, filed on Oct. 12, 2021, granted, now 11,813,291.
Claims priority of provisional application 63/090,518, filed on Oct. 12, 2020.
Prior Publication US 2023/0405045 A1, Dec. 21, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 33/42 (2006.01); A61J 1/10 (2006.01); A61K 9/08 (2006.01); A61M 5/168 (2006.01); A61M 39/02 (2006.01)
CPC A61K 33/42 (2013.01) [A61J 1/10 (2013.01); A61K 9/08 (2013.01)] 20 Claims
 
1. A sterile ready-to-use aqueous potassium solution, comprising potassium phosphates and sodium chloride, wherein the solution comprises between 1.5 mmol/100 mL and 15 mmol/100 ml phosphorous and equal or less than 50 mcg/L aluminum, and wherein the solution has a pH of between 2 and 6.